1. Home
  2. PEBO vs DVAX Comparison

PEBO vs DVAX Comparison

Compare PEBO & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEBO
  • DVAX
  • Stock Information
  • Founded
  • PEBO 1902
  • DVAX 1996
  • Country
  • PEBO United States
  • DVAX United States
  • Employees
  • PEBO N/A
  • DVAX N/A
  • Industry
  • PEBO Major Banks
  • DVAX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PEBO Finance
  • DVAX Health Care
  • Exchange
  • PEBO Nasdaq
  • DVAX Nasdaq
  • Market Cap
  • PEBO 1.1B
  • DVAX 1.2B
  • IPO Year
  • PEBO N/A
  • DVAX 2004
  • Fundamental
  • Price
  • PEBO $28.17
  • DVAX $9.83
  • Analyst Decision
  • PEBO Buy
  • DVAX Buy
  • Analyst Count
  • PEBO 7
  • DVAX 4
  • Target Price
  • PEBO $36.14
  • DVAX $26.50
  • AVG Volume (30 Days)
  • PEBO 132.5K
  • DVAX 1.3M
  • Earning Date
  • PEBO 10-21-2025
  • DVAX 11-06-2025
  • Dividend Yield
  • PEBO 5.83%
  • DVAX N/A
  • EPS Growth
  • PEBO N/A
  • DVAX N/A
  • EPS
  • PEBO 2.93
  • DVAX N/A
  • Revenue
  • PEBO $554,422,000.00
  • DVAX $316,268,000.00
  • Revenue This Year
  • PEBO N/A
  • DVAX $23.23
  • Revenue Next Year
  • PEBO $3.45
  • DVAX $16.57
  • P/E Ratio
  • PEBO $9.61
  • DVAX N/A
  • Revenue Growth
  • PEBO 9.54
  • DVAX 26.66
  • 52 Week Low
  • PEBO $26.21
  • DVAX $9.20
  • 52 Week High
  • PEBO $37.07
  • DVAX $14.63
  • Technical
  • Relative Strength Index (RSI)
  • PEBO 38.00
  • DVAX 44.18
  • Support Level
  • PEBO $27.49
  • DVAX $9.71
  • Resistance Level
  • PEBO $29.98
  • DVAX $10.12
  • Average True Range (ATR)
  • PEBO 0.68
  • DVAX 0.26
  • MACD
  • PEBO -0.20
  • DVAX -0.01
  • Stochastic Oscillator
  • PEBO 23.83
  • DVAX 26.97

About PEBO Peoples Bancorp Inc.

Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: